Clinverse CEO to Speak at MAGI East 2013

Tim Immel to speak on compliance issues related to clinical trial payments.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

RALEIGH, NC (PRWEB) March 28, 2013

Clinverse, Inc., a global cloud-based financial management and payment platform for clinical trials, today announced that CEO Tim Immel has been selected to speak at MAGI East in Boston, MA on billing compliance issues associated with professionals managing complex clinical trial payments.

Tim will be a featured speaker in the session titled, “Master Class for Billing Compliance Professionals,” on May 5, 2013. Geared towards billing compliance professionals, the interactive program will cover complex reimbursement issues, recent industry developments, case studies and war stories that will be shared by contributing industry panelists. Tim will be presenting how to leverage technology in managing these complex billing issues.

Clinverse will also be exhibiting and conducting demos of the industry’s only global clinical trial payment solution, ClinPay® FLS, at MAGI East. The conference offers more than 90 individual workshops centered around sponsor and site operations, contracts, budgeting, billing, regulatory compliance, quality and other clinical research-related topics. Over 500 attendees are expected.

About Clinverse, Inc.

Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed, ClinPay® FLS, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn